Volume 32, Number 5—May 2026
CME ACTIVITY - Research
Frequency and Duration of Diagnostic Delays Associated with Coccidioidomycosis and Risk Factors for Missed Diagnoses, United States
Desmond D. Barber, Alan T. Arakkal, George R. Thompson, John W. Baddley, Joe E. Cavanaugh, Aaron C. Miller, and Philip M. Polgreen
Table 1
Baseline characteristics of study population in study of frequency and duration of diagnostic delays associated with coccidioidomycosis and risk factors for missed diagnoses, United States*
| Characteristic | Value |
|---|---|
| Age at diagnosis, y | |
| <18 | 1,686 (6.3) |
| 18–34 | 3,531 (13.1) |
| 35–44 | 4,026 (15.0) |
| 45–54 | 5,581 (20.7) |
| 55–64 | 6,930 (25.8) |
| >65 | 5,151 (19.1) |
| Mean (+SD) | 50.1 (18.4) |
| Median (IQR) |
52.0 (23.0) |
| Sex | |
| M | 13,056 (48.5) |
| F |
13,849 (51.5) |
| Database source | |
| Commercial | 21,573 (80.2) |
| Medicare | 4,806 (17.9) |
| Medicaid |
526 (2.0) |
| Enrollment time before index diagnosis, y | |
| <2 | 7,177 (26.7) |
| <3 | 12,219 (45.4) |
| >3 | 14,686 (54.6) |
| Mean (+SD) | 4.4 (3.4) |
| Median (IQR) | 3.3 (3.9) |
*Values are no. (%) patients except as indicated. IQR, interquartile range.
Page created: March 23, 2026
Page updated: May 11, 2026
Page reviewed: May 11, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.